Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriene in morphea
NCT02411643Phase 1Terminated
- Sponsor
- Northwestern University
- Start
- Mar 2015
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of calcipotriol in morphea, sponsored by Northwestern University. Primary endpoint: Change of Gene Expression From Skin Biopsy at 3 months. Started Mar 2015; status: terminated.
02
Drugs
calcipotriol
03
Conditions
morphea
Beyond the preview
Go deeper on NCT02411643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02411643.